发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 39 |
| England | 34 |
| India | 33 |
| Iran | 27 |
| Switzerland | 27 |
| CHINA MAINLAND | 23 |
| France | 22 |
| GERMANY (FED REP GER) | 22 |
| Japan | 16 |
| South Korea | 14 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS & ... | 22 |
| US FOOD & DRUG ADMINISTRATION (FDA) | 15 |
| WORLD HEALTH ORGANIZATION | 15 |
| SANOFI-AVENTIS | 13 |
| INDIAN COUNCIL OF AGRICULTURAL RESEARCH (ICAR) | 10 |
| PAUL EHRLICH INSTITUTE | 8 |
| HEALTH CANADA | 7 |
| SERUM INST INDIA PVT LTD | 7 |
| LE RESEAU INTERNATIONAL DES INSTITUTS PASTEUR ... | 6 |
| CENTERS FOR DISEASE CONTROL & PREVENTION - USA | 5 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Therapeutic monoclonal antibody N-glycosylation Structur... | 21 |
| Poly(lactic-co-glycolic acid)(PLGA)/TiO2 nanotube bioact... | 10 |
| Current status and future prospective of vaccine develop... | 8 |
| Human challenge trials in vaccine development, Rockville... | 7 |
| Comparison of reverse-transcriptase qPCR and droplet dig... | 7 |
| Biochemical characterization, stability, and pathogen sa... | 7 |
| Considering clonality: A regulatory perspective on the i... | 6 |
| Construction of scaffolds composed of acellular cardiac ... | 6 |
| Establishment of the first International Standard for hu... | 5 |
| Interlaboratory comparison about feasibility of insolubl... | 5 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| VACCINE | 71 |
| BIOLOGICALS | 69 |
| SCI REP-UK | 39 |
| J VIROL METHODS | 35 |
| VIRUSES-BASEL | 29 |
| TOXINS | 23 |
| PLOS ONE | 22 |
| J PHARM SCI-US | 18 |
| INT J MOL SCI | 16 |
| MABS-AUSTIN | 16 |